Legionella and pseudomonas were found in water meant for hand washing in a unit where medicines for cancer patients were prepared, HSJ has learned.
The Department of Health and Social Care has told trusts not to stockpile products, amid growing concern over the impact of novel coronavirus on medical supplies.
A specialist trust is being sued for nearly £2m by a Luxembourgian pharmaceutical company over allegations of wrongdoing by the provider’s subsidiary company, HSJ can reveal.
Former health secretary Jeremy Hunt has urged his successor to find a way to ensure patients can access a high cost drug which is subject to a legal challenge against the National Institute for Health and Care Excellence.
A national strategy is needed to tackle health risks linked to antipsychotic drugs because current policy is letting tens of thousands of people fall through the gaps, commissioners in London are warning.
Poorly-implemented electronic prescribing systems in NHS hospitals are putting patients’ lives at risk, the NHS’s safety watchdog has warned.
A deal has been struck to make a life-extending cystic fibrosis drug available on the NHS for the first time.
The NHS will be exposed to more risk by the government’s latest Brexit deal than by Theresa May’s original agreement, health service experts and lobby groups have told HSJ.
Ministers have confirmed plans for a ban on the export of certain medicines, starting with a group of 24 drugs including 19 hormone replacement therapy treatments, ahead of the no-deal Brexit deadline at the end of this month.
Jeremy Corbyn says a Labour government would create a state-run pharmaceutical company to make generic versions of drugs the NHS cannot afford.
NHS chiefs have urged ministers to publish their up-to-date plans for a no-deal Brexit, in the wake of the release of Project Yellowhammer documents.
Fresh concerns have been raised that drugs stockpiled for a no-deal Brexit could be sold off before the 31 October deadline unless ministers intervene.
The NHS and the national medical regulator could face legal action over the shortage of intravenous feed supplies for hundreds of UK patients, HSJ has learned.
Sir Andrew Dillon will step down as the chief executive of the National Institute for Health and Care Excellence in March 2020 after more than 20 years in the role.
A national safety investigation has been launched into the NHS’ use of so-called ‘smart pumps’ after three patients received an overdose of the powerful opioid fentanyl.
The Medicines and Healthcare products Regulatory Agency has appointed an interim chief executive.
Senior clinicians have called for a review into how hundreds of patients have been left without intravenous food after action by the medical regulator severly curtailed its supply.
Dozens of patients including children have now been admitted to hospital because of the national shortage of intravenous food supplies for patients who cannot eat normal food, HSJ has learned.
The shortage of intravenous feed supplies affecting hundreds of patients across the country has been declared a national emergency incident by NHS leaders.
A regulator has defended its actions which caused delays to the supply of life-saving intravenous feed for hundreds of patients with HSJ learning some are now being admitted to hospital.
A drug used in most caesarean sections in the UK is expected to be unavailable for the next two weeks, prompting concerns some trusts may run out of supplies.
Ministers must act “very, very soon” to re-boot contingency plans for a no deal Brexit if the NHS and suppliers are to be ready for the UK to crash out of the EU on 31 October, NHS England’s chief executive has warned.
A new national “unit” is being established, with its own “chief executive”, to oversee innovation and medicines, the Department of Health and Social Care has announced.
Three pharmaceutical companies – including one which took NHS England to court over the design of a billion-pound tender – have been awarded contracts to supply drugs as part of a bid to eradicate hepatitis C by 2025.
Clinical commissioning groups could face renewed pressure to fund an expensive thyroid drug under NHS England revised guidance, due to be published shortly.
Patient groups have called NHS England “unbelievably arrogant” for failing to listen to patients during drug funding reviews.
NHS suppliers have been told to contact a new 24/7 call centre run by the Department of Health and Social Care if they experience disruption to their deliveries following a no-deal Brexit.
Councils in London are seeking additional funding from NHS England to help deal with cost pressures arising from trials for an HIV drug.
The number of generic drugs being sold above national tariff rose to its highest rate in over two years at the start of 2019, despite national efforts to cut this number.
Regulators and policymakers are at a loss for how to stop people accessing dangerous medicines using online services overseas, the outgoing chief inspector of GPs has said.